GravitasThe Life Price: A Healthcare Cost Crisis | deep dive$
PeerTube
California Politics HuddleCPH Daily Bulletin 10/16/2025
In shot across #BigPharma's bow, #California will sell its own #insulin
https://www.politico.com/news/2025/10/16/california-becomes-the-first-state-to-sell-insulin-00611163
Sojourner00Democrats vs. MAGA
#minimumwage #childcare #infrastructure #cleanenergy #workerrights #unions #drugcosts #foodcosts #homecosts #medicaid #medicare #guncontrol #publiceducation #gerrymandering #immigration
#minimumwage #childcare #infrastructure #cleanenergy #workerrights #unions #drugcosts #foodcosts #homecosts #medicaid #medicare #guncontrol #publiceducation #gerrymandering #immigration
Danny Boling ☮️The good news is that patients managing their pain after surgery now have an alternative to the extreme differences in treatment of temporary pain using opioids and, on the other end of the spectrum, OTC meds like Tylenol.
The bad but not-unexpected news is that the new medicine is US$15.50 for each pill. 🙄
https://apnews.com/article/nonopioid-painkiller-fda-vertex-pharmaceuticals-b1dd4276fce3d88ff32e3062e95f408f
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
FDA approves painkiller designed to eliminate risks of addiction associated with opioids
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids. The Food and Drug Administration approved the pill from Vertex Pharmaceuticals for acute pain that often occurs after surgery or injuries. It's the first new pharmaceutical approach to treating pain in 20 years. But the medication’s modest effectiveness shows just how challenging it is to find new ways of managing pain. Vertex's drug was better than a dummy pill at reducing pain after surgery, but it didn't outperform opioid treatment. Vertex is studying the drug for a number of other conditions, including chronic nerve pain.
William Lindsey 
"The healthcare access of about 24 million people who bought their health insurance through the Affordable Care Act (ACA) this year is now at risk.
Trump also repealed Biden-era orders to cut the cost of prescription drugs for people using the government health insurance programs Medicare and Medicaid. The core beneficiaries are older and lower-income Americans."
#Trump #Republicans #healthcare #Medicare #Medicaid #DrugCosts #PharmaceuticalIndustry
/7
""Donald Trump has signed several executive orders that put more than 20 million lower-income and middle-class Americans’ access to healthcare in jeopardy.
Within two days of his return to office, the president had ordered the repeal of Biden-era directives that had expanded Americans’ healthcare access and options."
~ Clea Skopeliti
#Trump #Republicans #healthcare #Medicare #Medicaid #DrugCosts #PharmaceuticalIndustry
/6
nomotime#WhiteHouse List of #Trump2.0 Initial #ExecutiveOrders Roll Back ~100 Biden orders.
Including:
Executive Order #14087 of October 14, 2022 (Lowering #Prescription #DrugCosts for Americans).
Catherine Collingwood Estes"[T]he government has alleged that various #DrugManufacturers used charities to improperly cover Medicare patients' copays," while simultaneously increasing their prices. #Pharmacy #DrugCosts #Kickbacks https://buff.ly/3U6e5h4
Susan Larson ♀️🏳️🌈🏳️⚧️🌈Your #guide to the #presidentialcandidates’ #views on #healthcare.
#Healthcare — #Medicare, #DrugCosts, The fate of the #AffordableCareAct — and who would handle it best — has continued to be contested turf in the final weeks of the #presidentialcampaign.
Trump has focused on #cutting #government #spending, he said, while Harris has emphasized #expanding #coverage and #affordability.
https://www.latimes.com/politics/story/2024-10-03/2024-election-harris-trump-healthcare-voter-guide
EURACTIV HealthAlzheimer’s drug lecanemab, EMA re-examining marketing authorisation [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/alzheimers-drug-lecanemab-ema-re-examining-marketing-authorisation/?utm_source=dlvr.it&utm_medium=mastodon #accesstohealthcare #AlzheimersDisease #DrugCosts #EUPharmaPackage
